版本:
中国

BRIEF-Oncosec Medical says entered into technology access program agreement with Inhibrx

March 14 Oncosec Medical Inc

* Oncosec medical inc says entered into a technology access program (tap) agreement with inhibrx, lp

* Oncosec medical- inhibrx will use co's proprietary gene delivery technologies; genesis research generator, proprietary applicators Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐